Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Estrogen receptor β signaling induces autophagy and downregulates Glut9 expression.

Zeng M, Chen B, Qing Y, Xie W, Dang W, Zhao M, Zhou J.

Nucleosides Nucleotides Nucleic Acids. 2014;33(7):455-65. doi: 10.1080/15257770.2014.885045.

PMID:
24972010
2.

Estrogen receptor beta (ERβ) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter gene.

Guido C, Panza S, Santoro M, Avena P, Panno ML, Perrotta I, Giordano F, Casaburi I, Catalano S, De Amicis F, Sotgia F, Lisanti MP, Andò S, Aquila S.

Cell Cycle. 2012 Aug 1;11(15):2911-21. doi: 10.4161/cc.21336. Epub 2012 Aug 1.

PMID:
22810004
3.
4.
5.

[Influence of pertussis toxin on GPER-mediated activation of phosphatidylinositol 3-kinase/protein kinase B signaling induced by 17β-estradiol in endometrial carcinoma cells].

Guo RX, Lei J, Wang XY, Ge X, Hu DM, Ma XY, Li LX, Qiao YH.

Zhonghua Fu Chan Ke Za Zhi. 2013 Feb;48(2):129-33. Chinese.

PMID:
23544495
6.

Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.

Saxena R, Fatima I, Chandra V, Blesson CS, Kharkwal G, Hussain MK, Hajela K, Roy BG, Dwivedi A.

Steroids. 2013 Nov;78(11):1071-86. doi: 10.1016/j.steroids.2013.07.004. Epub 2013 Jul 26.

PMID:
23891847
7.

Activation of ERbeta increases levels of phosphorylated nNOS and NO production through a Src/PI3K/Akt-dependent pathway in hypothalamic neurons.

Gingerich S, Krukoff TL.

Neuropharmacology. 2008 Oct;55(5):878-85. doi: 10.1016/j.neuropharm.2008.06.058. Epub 2008 Jul 4.

PMID:
18652836
8.

Mouse GLUT9: evidences for a urate uniporter.

Bibert S, Hess SK, Firsov D, Thorens B, Geering K, Horisberger JD, Bonny O.

Am J Physiol Renal Physiol. 2009 Sep;297(3):F612-9. doi: 10.1152/ajprenal.00139.2009. Epub 2009 Jul 8.

9.

Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.

Rossi V, Bellastella G, De Rosa C, Abbondanza C, Visconti D, Maione L, Chieffi P, Della Ragione F, Prezioso D, De Bellis A, Bellastella A, Sinisi AA.

J Cell Physiol. 2011 May;226(5):1334-9. doi: 10.1002/jcp.22461.

PMID:
20945400
11.

Knockdown of DEPTOR induces apoptosis, increases chemosensitivity to doxorubicin and suppresses autophagy in RPMI-8226 human multiple myeloma cells in vitro.

Zhang H, Chen J, Zeng Z, Que W, Zhou L.

Int J Mol Med. 2013 May;31(5):1127-34. doi: 10.3892/ijmm.2013.1299. Epub 2013 Mar 12.

PMID:
23503641
12.

Upregulation of estrogen receptor mediates migration, invasion and proliferation of endometrial carcinoma cells by regulating the PI3K/AKT/mTOR pathway.

Hou X, Zhao M, Wang T, Zhang G.

Oncol Rep. 2014 Mar;31(3):1175-82. doi: 10.3892/or.2013.2944. Epub 2013 Dec 23.

PMID:
24366110
13.

Desmethylanhydroicaritin inhibits NF-kappaB-regulated inflammatory gene expression by modulating the redox-sensitive PI3K/PTEN/Akt pathway.

Kim JH, Lee G, Cho YL, Kim CK, Han S, Lee H, Choi JS, Choe J, Won MH, Kwon YG, Ha KS, Kim YM.

Eur J Pharmacol. 2009 Jan 14;602(2-3):422-31. doi: 10.1016/j.ejphar.2008.10.062. Epub 2008 Nov 9.

PMID:
19027002
14.

Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.

Wei Y, Zhang Z, Liao H, Wu L, Wu X, Zhou D, Xi X, Zhu Y, Feng Y.

Oncol Rep. 2012 Feb;27(2):504-10. doi: 10.3892/or.2011.1536. Epub 2011 Nov 8.

PMID:
22075757
15.

Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.

Cotrim CZ, Fabris V, Doria ML, Lindberg K, Gustafsson JÅ, Amado F, Lanari C, Helguero LA.

Oncogene. 2013 May 9;32(19):2390-402. doi: 10.1038/onc.2012.261. Epub 2012 Jul 2.

PMID:
22751110
16.

Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.

Yu CP, Ho JY, Huang YT, Cha TL, Sun GH, Yu DS, Chang FW, Chen SP, Hsu RJ.

PLoS One. 2013;8(2):e56667. doi: 10.1371/journal.pone.0056667. Epub 2013 Feb 27.

17.

Four-and-a-half-LIM protein 1 down-regulates estrogen receptor α activity through repression of AKT phosphorylation in human breast cancer cell.

Zhang F, Feng F, Yang P, Li Z, You J, Xie W, Gao X, Yang J.

Int J Biochem Cell Biol. 2012 Feb;44(2):320-6. doi: 10.1016/j.biocel.2011.11.002. Epub 2011 Nov 10.

PMID:
22094188
18.

Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance (review).

Hafsi S, Pezzino FM, Candido S, Ligresti G, Spandidos DA, Soua Z, McCubrey JA, Travali S, Libra M.

Int J Oncol. 2012 Mar;40(3):639-44. doi: 10.3892/ijo.2011.1312. Epub 2011 Dec 20. Review.

PMID:
22200790
19.

Neferine from Nelumbo nucifera induces autophagy through the inhibition of PI3K/Akt/mTOR pathway and ROS hyper generation in A549 cells.

Poornima P, Weng CF, Padma VV.

Food Chem. 2013 Dec 15;141(4):3598-605. doi: 10.1016/j.foodchem.2013.05.138. Epub 2013 Jun 7.

PMID:
23993526
20.

17alpha-estradiol-induced VEGF-A expression in rat pituitary tumor cells is mediated through ER independent but PI3K-Akt dependent signaling pathway.

Banerjee S, Saxena N, Sengupta K, Banerjee SK.

Biochem Biophys Res Commun. 2003 Jan 3;300(1):209-15.

PMID:
12480545

Supplemental Content

Support Center